Form 4: Pitney Bowes Interim CEO Lance Rosenzweig Reports Stock Transactions

Sentiment:

SEC Form 4


Interim CEO of Pitney Bowes, Lance Rosenzweig, reports acquisition and disposal of common stock and restricted stock units.

Summary

  • On May 22, 2024, Lance Rosenzweig, Interim CEO of Pitney Bowes, reported transactions involving Pitney Bowes common stock and restricted stock units (RSUs).
  • Rosenzweig acquired 75,615 shares of common stock at $0.00 and disposed of 28,627 shares at $5.255.
  • He also acquired 302,458 restricted stock units and disposed of 75,615 restricted stock units.
  • Following these transactions, Rosenzweig beneficially owns 56,988 shares of common stock and 247,675 restricted stock units.
  • The RSUs vest in 25% intervals on 5/22/2024, 8/19/2024, 11/18/2024, and 2/17/2025.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting stock transactions, which carries a neutral sentiment.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency into the trading activities of key personnel, which can be of interest to investors.

Stakeholder Impact

  • Shareholders may be interested in the trading activity of the Interim CEO.

Key Dates

DateDescription
April 5, 2024Date of Power of Attorney execution.
May 22, 2024Date of stock transactions and RSU grant.
May 22, 2024First vesting date for RSUs (25%).
August 19, 2024Second vesting date for RSUs (25%).
November 18, 2024Third vesting date for RSUs (25%).
February 17, 2025Final vesting date for RSUs (25%).
May 23, 2024Date of Form 4 signature.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.